market
Altria Sues FDA Over Missed Review Deadlines for Tobacco ProductsAltria is taking the FDA to court over blown statutory deadlines for product reviews, claiming the agency's recent fixes haven't solved the backlog.
PouchDaily topic
ALTRIA
Nicotine-pouch reporting, research and analysis connected to ALTRIA.
market
Altria and PMI sign manufacturing deal — cigarette tax savings earmarked for smoke-free and pouch investmentThe two companies behind ZYN and on! — the largest U.S. nicotine pouch brands — have signed a contract manufacturing deal for cigarettes. The financial logic is a tax rebate on exports, but Altria says the savings will fund its smoke-free Vision, including nicotine pouches.
market
On! Pouch Volume Hits 47.2M Cans — But Share Still Falls as ZYN and Velo Outpace Altria's GrowthAltria's On! Plus rollout drove Q2 volume to 47.2 million cans, yet On!'s retail share dropped to 13.9% in H1 2026 (down from 16.8% a year earlier) as the $13.4B pouch category grows faster than On! can capture it.
science
Altria-funded study: smokers who switched to on! pouches saw gum inflammation drop 28%A 24-week randomised trial funded by Altria found that adult smokers who switched to on! nicotine pouches had significantly less gum inflammation, bleeding, and tooth staining than those who kept smoking. Every author is an Altria employee or paid consultant — so the caveats matter as much as the results.
market
LOOP nicotine pouches land in South Africa as Altria and KT&G push into AfricaSwedish pouch maker ASF — acquired by Altria and KT&G in December 2025 — launched its LOOP brand in South Africa with three hyper-strong variants. It is the first major expansion move under the new ownership and a bet that Africa is the next growth frontier for nicotine pouches.
regulation
Health groups sue the FDA as agency greenlights 30 nicotine pouch productsThe FDA has authorized 30 nicotine pouch products in 2026 — including 20 ZYN pouches with reduced-risk claims and four new flavored on! pouches. Public health groups, pediatricians and parents responded by suing the agency, arguing its enforcement policy lets products reach the market without legally required scientific review. The American Heart Association says the program was "never adequately explained to the public."
market
KT&G and Altria Drop $1B+ on Swedish Pouch Maker ASFTwo tobacco giants just made the biggest bet yet on nicotine pouches, jointly acquiring Another Snus Factory for over $1 billion in late 2025.